BACKGROUND: There has been much controversy regarding the accuracy of grading pancreatic neuroendocrine tumors (PNETs) on fine-needle aspiration (FNA) biopsy. The objectives of this study were to evaluate whether grading according to the fraction of Ki-67-positive tumor cells (the Ki-67 proliferation index) on material from endoscopic ultrasoundguided FNA biopsies correlated with grading on surgical resection specimens and to evaluate the minimum amount of FNA material needed. METHODS: A case series of 27 PNETs with FNA biopsies and corresponding surgical resection specimens at the authors' institution were evaluated. Tumors were graded on FNA and surgical specimens with an evaluation of Ki-67 index according to 2010 World Health Organization criteria. Chart reviews were conducted to evaluate recurrence or clinical progression in patients who were being managed conservatively with observation. RESULTS: The evaluation of grading between FNA and tumor resection specimens revealed that 22 of 26 FNA specimens (84.6%) had Ki-67 results comparable to those in the corresponding surgical resection specimens, thus allowing for accurate grading.
INTRODUCTION
Pancreatic neuroendocrine tumors (PNETs) are relatively rare, but increased detection through imaging of these tumors and subsequent studies have led to an increased understanding of their biologic behavior, which resulted in new diagnostic terminology and a new grading system by the World Health Organization (WHO) in 2010 1 based on the European Neuroendocrine Tumor Society (ENETS) classification. 2 It has been demonstrated that the WHO grading system is a meaningful prognostic indicator for assessing the clinical outcome of patients who undergo surgical resection of PNETs. [3] [4] [5] Before surgical resection, most PNETs are diagnosed by endoscopic ultrasound-guided fine-needle aspiration (FNA) biopsy. Grading of PNETs on FNA, as on surgical resection, is becoming the standard of care, mainly to guide surgical management. The revised 2016 ENETS guidelines recommend curative resection of nonfunctional PNETs in the absence of nonresectable metastases. The possibility of nonoperative management has been investigated for patients who have asymptomatic, sporadic PNETs measuring <2 cm with favorable outcomes, 6 but long-term follow-up data are lacking to cement those findings into current practice. Our institution has incorporated grading into the patient-evaluation algorithm, in conjunction with the updated National Comprehensive Cancer Network (NCCN) guidelines. The 2017 NCCN cancer guidelines incorporate the finding that observation can be considered in patients who have nonfunctioning, small (2 cm), incidentally discovered tumors based on surgical risk, tumor location, and patient comorbidities. 7 Grading on FNA has played an important role in conjunction with these factors. Grading depends on the proliferative rate, as determined by mitotic activity and the fraction of Ki-67-positive tumor cells (the Ki-67 proliferation index). Although mitotic activity has been known to be subjective and is difficult to interpret on FNA, various studies have demonstrated that Ki-67 index on FNA is reproducible on surgical specimens and is predictive of patient survival. [8] [9] [10] Ki-67 index may even be a more promising prognostic marker for PNETs than mitoses. 11 Although there is a recommendation by the WHO grading system to count 2000 cells to determine the Ki-67 index, attaining this number is not always feasible or practical on FNA specimens, which may contain scant material. In such scant specimens, the accuracy of Ki-67 index on FNA has been a concern. Studies have addressed the intratumoral heterogeneity, which causes sampling errors on FNA and the subsequent possibility of inaccurate Ki-67 index, with the resulting recommendation that adequate cellularity (>2000 cells) must be aspirated to correlate the Ki-67 index with the surgical specimen. 10, 12 Other studies have indicated that pancreatic FNA specimens are less specific for differentiating between grades of PNETs, with weaker correlations with surgical specimens. 13, 14 In the current report, we address multiple issues. The main issue involves the accuracy of grading on FNA cell blocks and its correlation with grading on the final resection specimen, especially because our clinical institution uses the Ki-67 index as a major determinant in patient management. In addition, cell blocks with various numbers of cells were evaluated to address the issue of adequate counts on FNA. We also address another area of disagreement for Ki-67 index evaluation on FNA, which is the technique of counting, with some suggesting image assessment of tumors or manual counting rather than "eyeballing." The fairly novel, camera-captured image approach has been reported in the literature with high reliability and reproducibility; however, this requires expensive equipment and is time consuming. 15 Finally, we also determined the clinical outcome of patients who did not undergo surgical resection of their PNET and were followed by their surgeon based on institutional protocol.
MATERIALS AND METHODS
A retrospective review at our institution from 1998 to 2017 was performed and yielded 68 PNETs. Patient characteristics, cytologic and surgical results, and patient clinical follow-up were reviewed. The most recent date of follow-up was considered valid if there were pertinent clinical notes or comprehensive imaging studies to exclude recurrence or metastasis. Inclusion criteria consisted of a diagnosis of PNET by FNA with a corresponding, subsequent surgical resection, which resulted in 38 eligible patients. Further evaluation of these patients yielded a final count of 27 eligible cases for the study. Patients were excluded if they had nondiagnostic tissue on FNA, an extrapancreatic tumor site with pancreatic metastasis, a solely extrapancreatic tumor site, lack of FNA performed when the patient underwent surgical resection, lack of surgical resection performed at our institution when the patient underwent FNA biopsy (often because of resection at an outside institution or evidence of metastatic PNET with a treatment plan of chemotherapy alone), if the patient had died, and if the patient was lost to follow-up. Slides previously assessed at the time of diagnosis were obtained and re-evaluated for surgical and cytology specimens. For surgical specimens, the diagnosis on hematoxylin-and-eosin-stained specimens was PNET. For the cytology material, the original smears, cells blocks, and immunohistochemical studies were re-reviewed for agreement with the previous diagnosis. Of 27 specimens, 26 were accurately diagnosed on FNA with supportive immunohistochemistry for a neuroendocrine origin at the time of re-reviewing the diagnosis. Of the 27 specimens, the 1 that was misdiagnosed was stained with neuroendocrine markers to verify the diagnosis of PNET.
Evaluation of the Ki-67 index was based on 2010 WHO criteria. For surgical specimens, either the original Ki-67 stain reported on the pathologist's previous diagnosis was used, or a Ki-67 evaluation was ordered for the study. For the cytology cell-block slides, no minimum number of cells was required for adequacy or inclusion in the study. In cytology FNA specimens that were evaluated for Ki-67 index at the time of original diagnosis (12 cases), Ki-67 index was re-reviewed on the original slides. For cytology FNA specimens that were not evaluated for Ki-67 index at the time of original diagnosis, Ki-67 immunohistochemical study performed on a section from the paraffin-embedded cell block and evaluated.
Immunohistochemical studies were performed on 5-lm sections of formalin-fixed, paraffin-embedded tissue. Slides were first deparaffinized and then rehydrated. Antigen retrieval was carried out with 0.01 M citrate buffer, pH 6.0. Slides were heated in a 770-Watt microwave oven for 14 minutes, cooled to room temperature, and rinsed in distilled water before staining. The slides were stained on the Dako Autostainer (Dako Corporation, Carpinteria, CA). The sections were first blocked for endogenous peroxidase activity with an application of Dual Endogenous Block (Dako Corporation) for 10 minutes, followed by a brief buffer wash. The sections were then incubated for 30 minutes with anti-Ki-67 mouse monoclonal antibody (clone MIB-1; catalog no. M7249; Dako Corporation) at a dilution of 1:100. After a buffer rinse, sections were incubated with the Dako Envision-Plus horseradish peroxidase detection reagent for 30 minutes. The sections were washed and treated with a solution of diaminobenzidine and hydrogen peroxide (Dako Corporation) for 10 minutes to produce the visible brown pigment. After rinsing, a toning solution (DAB Enhancer; Dako Corporation) was used for 2 minutes to enrich the color. After rinsing, the sections were counterstained with hematoxylin, dehydrated, and coverslipped with permanent media. Sections of tonsil or skin tissue with known positivity for the target proteins were used as positive controls for staining. Positive staining was defined as a dark-brown staining pattern, generally confined to the region of the nucleus. Scant staining, fine granular background staining, and no staining at all were considered negative.
In terms of interpreting the Ki-67 proliferation index, dark-brown nuclear staining was considered positive, based on WHO criteria, in grade 1 tumors that exhibited staining in 2% of cells and in grade 2 tumors that exhibited staining in 3% to 20% of cells. Two pathologists evaluated the Ki-67 results using 2 different techniques: manual counting and the eyeball method. Manual counting of cells on the cytologic cell block included counting the number of positive tumor cells in the areas of strongest labeling (hotspots) in conjunction with the total number of tumor cells present. Tumor cells on the cell block ranged from 50 to 2250 cells counted, and the majority of cell blocks had nearly 1000 cells. Eyeballing involved estimating the count of positive cells out of the total number of tumor cells present after evaluating multiple microscopic fields. Finally, correlation between the FNA and surgical resection Ki-67 index was assessed using the manual count on FNA, because this is a more precise evaluation technique compared with simple eyeballing. In this assessment, certain cases of FNA and resection specimens had a calculated Ki-67 index between 2% and 3%, thereby falling into the well recognized gray zone between grade 1 and 2 tumors. Therefore, we decided that a Ki-67 index <2.5% would be rounded down to 2%, and the tumor would be considered grade 1; and a Ki-67 index 2.5% would be rounded up to 3%, and the tumor would be considered grade 2.
Statistics were analyzed by comparing the Ki-67 results between cytologic and surgical specimens for grade 1 and 2 tumors. No grade 3 tumors were identified for which a Ki-67 comparison was available between FNA and surgical resection specimens (1 grade 3 tumor with a Ki-67 result was identified in the initial search but was excluded because of hepatic metastasis and nonsurgical therapy). The Fisher exact test was used to determine P values. A P value <.05 was considered statistically significant. This study was approved by the Institutional Review Board of UMass Medical School (identification number H00012053).
RESULTS

Patient and Tumor Characteristics for Patients Who Underwent Surgery
In total, 27 PNETs were analyzed. Patient characteristics included a median age of 58 years (range, 30-74 years). The cohort comprised 44% men and 56% women. The site of primary tumors varied in location, with 10 tumors in the pancreatic head, 2 in the pancreatic neck, 4 in the pancreatic body, 6 in the pancreatic tail, 3 involving multiple regions of the pancreas, and 2 that were primary duodenal tumors. The median tumor size was 2.1 cm (range, 0.8-14 cm). Tumors were approached surgically by enucleation, Original Article pancreaticoduodenectomy, central pancreatectomy, or distal pancreatectomy with or without splenectomy. Of 15 grade 1 resection specimens, 4 tumors measured 2 cm and had associated lymphatic and/or vascular invasion. Lymphatic and/or vascular invasion was identified in a total of 6 grade 1 resection specimens. Eleven of 12 grade 2 tumors were greater than 2 cm. Six patients diagnosed with grade 2 tumors on surgical resection had lymphatic and/or vascular invasion identified. Lymph node involvement was observed in a subset patients with grade 1 and 2 tumors who had lymphatic and/or vascular invasion. The majority of patients underwent complete resection (R0), 3 underwent resection with microscopic residual tumor (R1), and 1 underwent resection with macroscopic residual tumor (R2).
Assignment of Grade Based on the Ki-67 Index and Comparison Between FNA Biopsies and Surgical Specimens
The 27 cases evaluated included 15 grade 1 tumors and 12 grade 2 tumors based on Ki-67 evaluation in surgical resection specimens, and 26 of the 27 cases were initially diagnosed as neuroendocrine tumors on FNA. The 1 that was misdiagnosed as adenocarcinoma on FNA was from a patient who had a corresponding surgical resection specimen with a diagnosis of PNET; and the diagnosis of PNET on FNA was confirmed for our study by staining the incorrectly diagnosed cell block for chromogranin and synaptophysin. An evaluation of grading between FNA and tumor resection specimens revealed that 22 of 26 specimens (84.6%) had comparable Ki-67 results, thus allowing for an accurate diagnosis of grade on FNA in those tumors (Fig. 1) . One tumor (case 27) was composed of rare clusters and scattered, individual tumor cells with fitting morphology and immunohistochemical profile, in a background of abundant tumor necrosis and debris. Too few cells were present to reliably use as a denominator in estimating this tumor's grade; however, overall, the findings were suggestive of a moderate-grade to high-grade neuroendocrine tumor, which was confirmed on surgical resection (Fig. 2) . The correct diagnosis of grade 2 tumors, compared with grade 1 tumors, had 72.7% sensitivity, 93.3% specificity, a positive predictive value of 88.9%, a negative predictive value of 82.4%, and a P value of .00081. Of the 4 specimens with discrepant Ki-67 staining results, 3 had an FNA diagnosis of grade 1 tumor, but the final resection diagnosis revealed grade 2 tumor. It is noteworthy that 1 of these specimens (case 16) included a gray-zone Ki-67 index of 2.2% on FNA, which had been rounded down to 2% for purposes of comparison. One case had an FNA diagnosis of grade 2, but the final resection diagnosis revealed grade 1 tumor. These findings are detailed in Table 1 .
Manual Counting Versus Eyeballing
Of the 26 cases evaluated, 23 (88%) were in agreement between diagnosis by eyeball estimate and diagnosis by manual count of positive nuclei. More specifically, 15 cases (58%) had agreement on a grade 1 diagnosis, and 8 (31%) had agreement on a grade 2 diagnosis between the 2 methods. Three cases (11%) did not agree between the 2 methods: in 1 case, the eyeball method called grade 1 and the manual count called grade 2; in 2 cases, the eyeball method called grade 2 when the manual count called grade 1. This correlation is detailed in Table 1 . 
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Clinical Outcome of Patients Who Underwent Surgical Resection
Of the 27 cases described above, the median follow-up of patients from the time of diagnosis based on FNA to the last clinical note was 46 months (range, 1-137 months), and the median follow-up from the time of surgical resection to the last clinical note was 45 months (range, 1-136 months). Of all patients examined, 22 had no evidence of disease at the last clinical follow-up. One patient died shortly after surgery of an unknown cause without followup in the medical record. Four of 27 patients developed local recurrence or metastasis, and all presumably remain alive with disease and are being medically managed. One patient developed a local recurrence in both areas of previous resected nodules 8 months after undergoing a Beger procedure. This patient had a grade 1 tumor on FNA that measured 1.4 cm in greatest dimension (2 foci), underwent an R0 resection, and had no lymphovascular invasion. The other 3 patients had liver metastases (1 had metastasis biopsy confirmed at surgical resection, 1 had metastasis identified 8 months after surgery, and 1 had metastasis identified at an unknown date). Of these 3 patients, 2 had grade 2 tumors, and 1 had a grade 1 tumor; 2 were positive for lymphovascular invasion and had positive lymph nodes identified on resection, whereas the other had perineural invasion; all underwent R0 resection. The primary tumors in these 3 patients measured 5.4, 8.5, and 11.
Clinical Outcome of Patients Conservatively Managed Without Surgery
Six patients were identified for a watch-and-wait approach starting from 2009. The watch-and-wait approach included interval follow-up with imaging or chromogranin A/hormone levels. Factors considered for surveillance only included tumor grade, tumor size <2 cm, lack of hormone function, asymptomatic patient, stability without evidence of progression, patient comorbidities, and poor performance status/poor surgical candidate. The median patient age was 75 years (range, 65-86 years); 50% of patients were men, and 50% were women. The site of primary tumors included 3 tumors in the pancreatic head, 2 in the pancreatic body, and 1 in the pancreatic tail. Five tumors were small in size(<2 cm; range, 0.7-1.6 cm). One patient had a larger tumor (6 cm) and was selected for conservative management by the surgeon according to patient preference because of a well differentiated tumor and the patient's advanced age. Five tumors were called well differentiated or low grade on FNA diagnosis, and 1 was called PNET without commenting on differentiation. Three patients had a Ki-67 evaluation performed at the time of diagnosis, and all results were <2%. It was evident from the clinical notes that, in 4 of these 5 patients, grading played a major factor, in conjunction with other factors, in the decision to undergo clinical surveillance rather than resection. Patients had a median follow-up since diagnosis of 17 months (range, 1-71 months). No patients had disease progression at the last follow-up. Two of 6 patients were lost to followup after a short period (1 month and 5 months after diagnosis). Reasons for loss to follow-up included seeking an outside institution for a second opinion about surgical resection or death from unrelated causes shortly after diagnosis.
DISCUSSION
Diagnosing PNETs by FNA has become common practice, with evaluation to help guide management for the surgeon. Tumor size, lymph node status, and disease stage have played major roles in helping to triage these tumors for surgery. Size in particular has played an important role in surgical decision making, with a cutoff of 2 cm for determining eligibility for surgical resection. In a study by Ende and colleagues, no statistically significant difference in metastasis was observed between tumors <2 cm and >2 cm, suggesting that size alone may not be adequate for predicting patient outcome. 16 Other factors, such as histologic appearance, may play a role but have been associated with diverse clinical tumor behaviors and are not reliable in predicting patient outcome. Ki-67 index has more recently become an important factor in triaging patients for surgery, but it is not consistently evaluated on FNA among institutions. There also are conflicting data in the literature on the accuracy of Ki-67 index. Evaluating Ki-67 index and mitoses is the standard way to grade neuroendocrine tumors. However, mitoses were not specifically addressed in the current study because of subjectivity in counting, poor interobserver variability, and a history of under grading compared with Ki-67 index. The current results demonstrate that Ki-67 index is a relatively reliable marker for FNA specimens and correlates well with the Ki-67 value on corresponding surgical resection specimens. Thus, evaluating Ki-67 index on FNA specimens can help to distinguish the grade of PNETs, which ultimately is predictive of patient survival and can be useful for preoperative prognostic workup and patient management. Other studies have reported similar results for the accuracy of Ki-67 index, including concordance with surgical resections, supporting the use of Ki-67 index on FNA specimens. 9, 10, [17] [18] [19] The accuracy of Ki-67 index is of paramount importance, because multiple studies have cited a significant association between a higher Ki-67 index and the 3-tiered WHO grading system with metastatic disease and survival in patients with gastroenteropancreatic neuroendocrine tumors. [20] [21] [22] In this study, 4 patients had discrepant results between the FNA and final surgical resection diagnosis. Three tumors were under graded on FNA as grade 1, and, on resection, were called grade 2. This is likely because of sampling. Tumor heterogeneity allows for areas of the strongest nuclear staining (hotspots), within the tumor, which may not be adequately sampled on FNA. In addition, excessive hemorrhage can dilute the smear, leading to a false low count. 23 The 1 tumor that was over graded on FNA as grade 2, again, can be attributed to oversampling of a hotspot. However, it is noteworthy that tumor size and location also reportedly affect sampling adequacy. Carcinoid tumors of the midgut predominantly secrete serotonin, which has been linked to fibrogenesis. 24 Consequently, larger tumors (>1 cm) are more likely to have abundant intratumoral fibrosis, resulting in a higher chance of missing the cells of interest when performing FNA. Conversely, smaller tumors (<1 cm) have higher cellularity per unit area and minimal fibrosis. In addition, it has been demonstrated that tumors located in the pancreatic body and tail have higher sampling adequacy rates than lesions located in the pancreatic head. Hijioka et al reported that tumor size and location were independent predictors of sampling adequacy. 25 Indeed, the tumor in our series fit both categories, with a size of 8.5 cm and a location within the pancreatic head.
In terms of methods for counting Ki-67 index, a recent study of 4 different counting methods by Reid et al indicates that eyeballing is highly inaccurate, with poor reliability and reproducibility. In their study, a manual eye count also had poor reproducibility, whereas cameracaptured imaging was deemed most practical for obtaining the Ki-67 index with the highest interobserver agreement. 15 In contrast, our current study indicates that an eyeball estimation method of assessing Ki-67 index correlates well with a manual count method. Three discrepant cases (11.5%) had an approximately 0.8% to 2% or 3% difference in Ki-67 index between the eyeball and manual methods, which altered the reported tumor grade. This observation, that the percentage obtained between the 2 methods was not drastically different yet resulted in different grading, highlights the problem of borderline results for Ki-67 at the grade 1/2 cutoff. The 2010 WHO classification makes no mention of how to categorize tumors that fall into this potential gray zone, allowing the pathologist to round either up or down or to state that this is a borderline tumor (which would warrant resection). However, this scenario remains under-studied, and future perspectives may help better define cutoff guidelines. In borderline cases, if the pathologist is not absolutely confident using the "eyeball" method that a count is <2%, perhaps a manual count or a camera-captured image approach is warranted to ensure accuracy. The latter technique has not been validated at our institution, thereby curtailing an effort to resolve the discrepant cases. Otherwise, for specimens with unequivocally low staining, the eyeball method seems to be an adequate method for estimating the Ki-67 index. Some investigators have reported the use of digital image analysis to calculate the Ki-67 index as an objective measure, but it is not widely used and also can produce inconsistent grading results, depending on the technique used. 26, 27 There has been ongoing debate about the adequate number of cells for determining the Ki-67 index in cell block material. The current results indicate a good correlation between FNA and surgical resection findings, even in specimens with low cell counts. Most specimens had 1000 cells counted, and the minimum count was 50 cells. Results from the 2 FNA specimens that had only 50 cells were in agreement with the corresponding surgical resection specimens with regard to tumor grade using Ki-67. The WHO 2010 classification of neuroendocrine neoplasms has recommended evaluating the Ki-67 index as a percentage of 500 to 2000 cells counted in hotspot areas with the strongest staining. 1 The ENETS has recommended counting at least 2000 cells for obtaining Ki-67 values on PNETs, which is not practical for clinical practice. 2 The study by Hasegawa and colleagues supports the notion of using >2000 tumor cells for Ki-67 evaluation. Those authors reported the highest concordance of Ki-67
Original Article index (90%) between FNA and surgical resection specimens when >2000 cells were aspirated, whereas the concordance was lower (74% and 77.8%) when specimens with <2000 cells were not excluded. 10 Our concordance of 84.6% between FNA and resection specimens included a majority of cases with far less than 2000 cells, including a minimum of 50 cells. The current study demonstrates that adequate cellularity can be much lower than that suggested in the literature and still can allow for the accurate quantification of Ki-67 when tumor comprises the majority of the aspirated material. Given the consistent use of Ki-67 index for grading PNETs at our institution, clinicians have more recently began to use Ki-67 index as a factor in triaging patients with PNETs for surgery or surveillance. The current study describes 6 patients who were considered for continued surveillance by imaging and assessment for functionality with hormonal status. Four of those patients seem to be doing well without any evidence of tumor progression, whereas 2 were lost to follow-up or died from unrelated causes within a few months. These data indicate that grading can play an important role in management and that low-grade tumors are predictive of a good patient outcome if the patient is conservatively managed and followed. The 2017 NCCN guidelines incorporate the finding that patients who have small, nonfunctioning tumors can be observed in the appropriate clinical context, as also stated in the ENETS consensus guidelines. 8, 28 A prospective study by Massironi and coworkers demonstrates that overall and progression-free survival in a cohort with small (<2 cm), well differentiated, grade 1 pancreatic neuroendocrine neoplasms was similar to the survival of patients who underwent resection for tumors that were either functional, grade 2 to 3, or measured >2 cm. Those authors concluded that the watch-and-wait approach for patients with early stage, low-grade, small PNETs appears to be safe and rational but needs larger studies. 29 Given the supportive results in our current study, a conservative approach for the appropriate patient can be justified. The current study demonstrates a good correlation between grading on FNA and surgical resection specimens using Ki-67 index, specifically with regard to the ability to distinguishing between grade 1 and 2 tumors with a statistically significant P value. We argue that Ki-67 index should be performed and reported on every FNA specimen with PNET, because the result can be a major factor in therapeutic decision making and surgical management.
Current guidelines indicate that surveillance can be considered for patients who have small, incidental, nonfunctioning tumors. We propose that grade 1 tumors should also be included within these guidelines. At our institution, the surgical team incorporates the grade of the tumor into their decision making. A reliable assessment of tumor grade allows clinicians to determine which patients are suitable for surveillance as opposed to resection. Factors that may affect grade analysis, such as the counting method used and cell adequacy, have been addressed in this study. The eyeball method had a good correlation with manual count, and cell blocks with smaller cell numbers than quoted in previous studies were adequate for diagnosis. Finally, the results in patients at our institution who were conservatively managed without experiencing disease progression indicate that surveillance is an acceptable method for managing low-grade, small, nonfunctioning tumors.
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